Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
NovImmune
220
NovImmune
Technology
Biotechnology
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Suggest edits
Founded
1998
Raised
$137.2M
Follow us
Also headquartered in Geneva
Seedstars World
Seedstars
ProtonMail
World Economic Forum
CERN
Index Ventures
Temenos
Silent Circle
WHO
IPCC
Companies in the same industry
VIDA Diagnostics
Cell Medica
Personalis, Inc.
Perlstein Lab
VivoSight OCT
CDx Life
Pulmatrix
Rubicon Genomics, Inc.
Onramp BioInformatics
Genohm
Alexa global traffic share
